We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New RNAi Treatment Targets Eye Inflammation

News   Feb 15, 2017 | Original story from Hokkaido University

 
New RNAi Treatment Targets Eye Inflammation

The newly developed RNAi agent suppressed chronic inflammation in the retinas of diabetic mice. The number of leukocytes (arrows) in the inflamed vasculature was significantly reduced in the RNAi-treated retina (right) comparing to the control experiment (left). Credit: Hokkaido University

 
 
 

RELATED ARTICLES

Bioengineered Spinal Discs Successfully Implanted into Goats

News

Engineered spinal discs integrated with native discs maintained their structure and showed near-native mechanical properties 2 months after implantation in a goat model, demonstrating feasibility of this approach.

READ MORE

DNA Origami Packed Full of Potent Anticancer Agents

News

Scientists have now developed a nanoplatform that selectively delivers small hairpin RNA transcription templates and chemotherapeutics into multidrug-resistant tumors. A deadly cocktail of gene-silencing elements and chemotherapeutic drugs effectively and selectively kills cells.

READ MORE

Cellphone-microchip Duo Detects HIV

News

A portable and affordable mobile diagnostic tool detects HIV viruses and monitors its management in resource-limited regions, utilizing a cellphone and nanotechnology.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE